91 results on '"Meier FA"'
Search Results
2. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors.
- Author
-
Meier FA and Jones BA
- Published
- 2005
- Full Text
- View/download PDF
3. Error detection in anatomic pathology.
- Author
-
Zarbo RJ, Meier FA, and Raab SS
- Published
- 2005
- Full Text
- View/download PDF
4. Environmental causes of cancer death
- Author
-
Greenberg Er and Meier Fa
- Subjects
Male ,Risk ,business.industry ,Cancer ,Environment ,Forensic Medicine ,medicine.disease ,Industrial pollution ,Environmental agent ,Pathology and Forensic Medicine ,Causes of cancer ,Cigarette smoking ,Neoplasms ,Environmental health ,Pathology ,medicine ,Damages ,Humans ,Female ,Epidemiologic data ,Environmental Pollution ,Epidemiologic Methods ,business ,Forensic autopsy - Abstract
People increasingly look to the forensic autopsy as a way of determining whether a particular cancer death was environmentally caused. The forensic pathologist must be diligent pursuing evidence that links potential environmental causes to cancer but must also educate the public providing reassurance that most cancers are not due to industrial pollution. Cigarette smoking and various life-style factors appear to account for more cancers than do man-made environmental contaminants. Assessing the possibility that a cancer death is due to a specific environmental agent requires extensive information. First, one must obtain an accurate history of lifetime occupational and environmental exposures. Second, one must analyze this information in view of epidemiologic data on the cancer risks associated with each exposure. Finally, one should seek to document through the autopsy that exposure to a potentially harmful agent actually occurred. The carefully done forensic autopsy can alert the public to dangerous conditions and can provide individuals a basis for recovery in court for damages due to harmful exposures.
- Published
- 1982
- Full Text
- View/download PDF
5. Computer Surveillance of Hospital-Acquired Infections and Antibiotic Use
- Author
-
Russell K. Hulse, Reed M. Gardner, Julie T. Jacobson, Meier Fa, John P. Burke, Jay A. Jacobson, Robert A. Larsen, Marlyn Conti, and Evans Rs
- Subjects
Drug Utilization ,medicine.medical_specialty ,medicine.drug_class ,business.industry ,Medical record ,Antibiotics ,Cephalosporin ,Surveillance Methods ,General Medicine ,Infectious disease (medical specialty) ,Epidemiology ,medicine ,Antibiotic use ,Intensive care medicine ,business - Abstract
Surveillance of hospital-acquired infections and antibiotic use is required of US hospitals. The time and cost needed to actively perform this surveillance can be extensive. We developed a computerized infectious disease monitor that automatically generates four types of surveillance "alerts" for patients (1) with hospital-acquired infections, (2) not receiving antibiotics to which their pathogens are susceptible, (3) who could be receiving less expensive antibiotics, or (4) who are receiving prophylactic antibiotics too long. Surveillance personnel using computer screening for two months found more hospital-acquired infections when compared with our traditional surveillance methods, while requiring only 35% of the time. In addition, alerts from the computer identified 37 patients not receiving appropriate antibiotics, 31 patients who could have been receiving less expensive antibiotics, and 142 patients, during one month, receiving prolonged cephalosporin prophylaxis. Computer screening can help focus the activities and improve the efficiency of hospital surveillance personnel. ( JAMA 1986;256:1007-1011)
- Published
- 1986
- Full Text
- View/download PDF
6. Surgical pathology case reviews before sign-out: a College of American Pathologists Q-Probes study of 45 laboratories.
- Author
-
Nakhleh RE, Bekeris LG, Souers RJ, Meier FA, and Tworek JA
- Published
- 2010
- Full Text
- View/download PDF
7. Clinical laboratory specimen rejection--association with the site of patient care and patients' characteristics: findings from a single health care organization.
- Author
-
Stark A, Jones BA, Chapman D, Well K, Krajenta R, Meier FA, and Zarbo RJ
- Published
- 2007
- Full Text
- View/download PDF
8. Anatomic pathology databases and patient safety.
- Author
-
Raab SS, Grzybicki DM, Zarbo RJ, Meier FA, Geyer SJ, and Jensen C
- Published
- 2005
- Full Text
- View/download PDF
9. Paenibacillus spp infection among infants with postinfectious hydrocephalus in Uganda: an observational case-control study.
- Author
-
Morton SU, Hehnly C, Burgoine K, Ssentongo P, Ericson JE, Kumar MS, Hagmann C, Fronterre C, Smith J, Movassagh M, Streck N, Bebell LM, Bazira J, Kumbakumba E, Bajunirwe F, Mulondo R, Mbabazi-Kabachelor E, Nsubuga BK, Natukwatsa D, Nalule E, Magombe J, Erickson T, Ngonzi J, Ochora M, Olupot-Olupot P, Onen J, Ssenyonga P, Mugamba J, Warf BC, Kulkarni AV, Lane J, Whalen AJ, Zhang L, Sheldon K, Meier FA, Kiwanuka J, Broach JR, Paulson JN, and Schiff SJ
- Subjects
- United States, Infant, Newborn, Child, Humans, Infant, Female, Pregnancy, Uganda epidemiology, Placenta, Case-Control Studies, Neonatal Sepsis complications, Paenibacillus genetics, Sepsis complications, Sepsis microbiology, Meningitis complications, Hydrocephalus epidemiology, Hydrocephalus etiology
- Abstract
Background: Paenibacillus thiaminolyticus is a cause of postinfectious hydrocephalus among Ugandan infants. To determine whether Paenibacillus spp is a pathogen in neonatal sepsis, meningitis, and postinfectious hydrocephalus, we aimed to complete three separate studies of Ugandan infants. The first study was on peripartum prevalence of Paenibacillus in mother-newborn pairs. The second study assessed Paenibacillus in blood and cerebrospinal fluid (CSF) from neonates with sepsis. The third study assessed Paenibacillus in CSF from infants with hydrocephalus., Methods: In this observational study, we recruited mother-newborn pairs with and without maternal fever (mother-newborn cohort), neonates (aged ≤28 days) with sepsis (sepsis cohort), and infants (aged ≤90 days) with hydrocephalus with and without a history of neonatal sepsis and meningitis (hydrocephalus cohort) from three hospitals in Uganda between Jan 13, 2016 and Oct 2, 2019. We collected maternal blood, vaginal swabs, and placental samples and the cord from the mother-newborn pairs, and blood and CSF from neonates and infants. Bacterial content of infant CSF was characterised by 16S rDNA sequencing. We analysed all samples using quantitative PCR (qPCR) targeting either the Paenibacillus genus or Paenibacillus thiaminolyticus spp. We collected cranial ultrasound and computed tomography images in the subset of participants represented in more than one cohort., Findings: No Paenibacillus spp were detected in vaginal, maternal blood, placental, or cord blood specimens from the mother-newborn cohort by qPCR. Paenibacillus spp was detected in 6% (37 of 631 neonates) in the sepsis cohort and, of these, 14% (5 of 37 neonates) developed postinfectious hydrocephalus. Paenibacillus was the most enriched bacterial genera in postinfectious hydrocephalus CSF (91 [44%] of 209 patients) from the hydrocephalus cohort, with 16S showing 94% accuracy when validated by qPCR. Imaging showed progression from Paenibacillus spp-related meningitis to postinfectious hydrocephalus over 1-3 months. Patients with postinfectious hydrocephalus with Paenibacillus spp infections were geographically clustered., Interpretation: Paenibacillus spp causes neonatal sepsis and meningitis in Uganda and is the dominant cause of subsequent postinfectious hydrocephalus. There was no evidence of transplacental transmission, and geographical evidence was consistent with an environmental source of neonatal infection. Further work is needed to identify routes of infection and optimise treatment of neonatal Paenibacillus spp infection to lessen the burden of morbidity and mortality., Funding: National Institutes of Health and Boston Children's Hospital Office of Faculty Development., Competing Interests: Declaration of interests KB is Principal Investigator on a Joint Global Health Trials grant from the UK Medical Research Council and has received travel grants and honoraria for speaking at Hot Topics in Neonatology. JEE has received honoraria for participation on the Data Safety Monitoring Board of AbbVie. BCW has received honoraria for participation on the Data Safety Monitoring Board for the Endoscopic versus Shunt Treatment of Hydrocephalus in Infants trial of the Hydrocephalus Clinical Research Network and is the Chairman of Neurokids. JNP has been employed by Genentech and N-Power Medicine; has held stocks and holds and is planning patents at Genentech and N-Power Medicine; has received honoraria for speaking at the International Human Microbiome Consortia meeting; and has received travel support from Genentech. All other authors declare no competing interests. The National Institutes of Health (NIH) Director's Pioneer Award 5DP1HD086071 and NIH Director's Transformative Award 1R01AI145057 has been given to SJS, and the Boston Children's Hospital Office of Faculty Development Career Development Award to SUM. No authors are employed by the NIH., (Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
10. Building Perinatal Pathology Research Capacity in Sub-Saharan Africa.
- Author
-
Bebell LM, Ngonzi J, Meier FA, Carreon CK, Birungi A, Kerry VB, Atwine R, and Roberts DJ
- Abstract
Introduction: Over two million stillbirths and neonatal deaths occur in sub-Saharan Africa (sSA) annually. Despite multilateral efforts, reducing perinatal mortality has been slow. Although targeted pathologic investigation can often determine the cause of perinatal death, in resource-limited settings, stillbirths, early neonatal deaths, and placentas are rarely examined pathologically. However, the placenta is a key source of diagnostic information and is the main determinant of fetal growth and development in utero , influencing child health outcomes., Methods: In 2016, our collaborative intercontinental group began investigating infectious perinatal death and adverse child health outcomes in Uganda. We developed and initiated a 4-day combined didactic/practical curriculum to train health workers in placental collection, gross placental examination, and tissue sampling for histology. We also trained a local technician to perform immunohistochemistry staining., Results: Overall, we trained 12 health workers who performed gross placental assessment for > 1,000 placentas, obtaining > 5,000 formalin-fixed tissue samples for research diagnostic use. Median placental weights ranged from 425 to 456 g, and 33.3% of placentas were < 10th percentile in weight, corrected for gestational age. Acute chorioamnionitis (32.3%) and maternal vascular malperfusion (25.4%) were common diagnoses., Discussion: Through a targeted training program, we built capacity at a university-affiliated hospital in sSA to independently perform placental collection, gross pathologic examination, and placental tissue processing for histology and special stains. Our training model can be applied to other collaborative research endeavors in diverse resource-limited settings to improve research and clinical capacity and competency for diagnostics and management of stillbirth, neonatal death, and child health outcomes., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Bebell, Ngonzi, Meier, Carreon, Birungi, Kerry, Atwine and Roberts.)
- Published
- 2022
- Full Text
- View/download PDF
11. Cytomegalovirus infections in infants in Uganda: Newborn-mother pairs, neonates with sepsis, and infants with hydrocephalus.
- Author
-
Hehnly C, Ssentongo P, Bebell LM, Burgoine K, Bazira J, Fronterre C, Kumbakumba E, Mulondo R, Mbabazi-Kabachelor E, Morton SU, Ngonzi J, Ochora M, Olupot-Olupot P, Mugamba J, Onen J, Roberts DJ, Sheldon K, Sinnar SA, Smith J, Ssenyonga P, Kiwanuka J, Paulson JN, Meier FA, Ericson JE, Broach JR, and Schiff SJ
- Subjects
- Adult, Female, Humans, Infant, Infant, Newborn, Risk Factors, Uganda epidemiology, Cytomegalovirus Infections complications, Cytomegalovirus Infections congenital, Cytomegalovirus Infections epidemiology, Hydrocephalus epidemiology, Sepsis epidemiology
- Abstract
Objectives: To estimate the prevalence of cytomegalovirus (CMV) infections among newborn-mother pairs, neonates with sepsis, and infants with hydrocephalus in Uganda., Design and Methods: Three populations-newborn-mother pairs, neonates with sepsis, and infants (≤3 months) with nonpostinfectious (NPIH) or postinfectious (PIH) hydrocephalus-were evaluated for CMV infection at 3 medical centers in Uganda. Quantitative PCR (qPCR) was used to characterize the prevalence of CMV., Results: The overall CMV prevalence in 2498 samples across all groups was 9%. In newborn-mother pairs, there was a 3% prevalence of cord blood CMV positivity and 33% prevalence of maternal vaginal shedding. In neonates with clinical sepsis, there was a 2% CMV prevalence. Maternal HIV seropositivity (adjusted odds ratio [aOR] 25.20; 95% confidence interval [CI] 4.43-134.26; p = 0.0001), residence in eastern Uganda (aOR 11.06; 95% CI 2.30-76.18; p = 0.003), maternal age <25 years (aOR 4.54; 95% CI 1.40-19.29; p = 0.02), and increasing neonatal age (aOR 1.08 for each day older; 95% CI 1.00-1.16; p = 0.05), were associated risk factors for CMV in neonates with clinical sepsis. We found a 2-fold higher maternal vaginal shedding in eastern (45%) vs western (22%) Uganda during parturition (n = 22/49 vs 11/50, the Fisher exact test; p = 0.02). In infants with PIH, the prevalence in blood was 24% and in infants with NPIH, it was 20%. CMV was present in the cerebrospinal fluid (CSF) of 13% of infants with PIH compared with 0.5% of infants with NPIH (n = 26/205 vs 1/194, p < 0.0001)., Conclusions: Our findings highlight that congenital and postnatal CMV prevalence is substantial in this African setting, and the long-term consequences are uncharacterized., (Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
12. Vaginal microbiome topic modeling of laboring Ugandan women with and without fever.
- Author
-
Movassagh M, Bebell LM, Burgoine K, Hehnly C, Zhang L, Moran K, Sheldon K, Sinnar SA, Mbabazi-Kabachelor E, Kumbakumba E, Bazira J, Ochora M, Mulondo R, Nsubuga BK, Weeks AD, Gladstone M, Olupot-Olupot P, Ngonzi J, Roberts DJ, Meier FA, Irizarry RA, Broach JR, Schiff SJ, and Paulson JN
- Subjects
- Adult, Bacteria genetics, Biodiversity, Cluster Analysis, Female, Humans, Lactobacillus genetics, Pregnancy, RNA, Ribosomal, 16S genetics, Uganda, Bacteria classification, Labor, Obstetric, Microbiota, Vagina microbiology
- Abstract
The composition of the maternal vaginal microbiome influences the duration of pregnancy, onset of labor, and even neonatal outcomes. Maternal microbiome research in sub-Saharan Africa has focused on non-pregnant and postpartum composition of the vaginal microbiome. Here we aimed to illustrate the relationship between the vaginal microbiome of 99 laboring Ugandan women and intrapartum fever using routine microbiology and 16S ribosomal RNA gene sequencing from two hypervariable regions (V1-V2 and V3-V4). To describe the vaginal microbes associated with vaginal microbial communities, we pursued two approaches: hierarchical clustering methods and a novel Grades of Membership (GoM) modeling approach for vaginal microbiome characterization. Leveraging GoM models, we created a basis composed of a preassigned number of microbial topics whose linear combination optimally represents each patient yielding more comprehensive associations and characterization between maternal clinical features and the microbial communities. Using a random forest model, we showed that by including microbial topic models we improved upon clinical variables to predict maternal fever. Overall, we found a higher prevalence of Granulicatella, Streptococcus, Fusobacterium, Anaerococcus, Sneathia, Clostridium, Gemella, Mobiluncus, and Veillonella genera in febrile mothers, and higher prevalence of Lactobacillus genera (in particular L. crispatus and L. jensenii), Acinobacter, Aerococcus, and Prevotella species in afebrile mothers. By including clinical variables with microbial topics in this model, we observed young maternal age, fever reported earlier in the pregnancy, longer labor duration, and microbial communities with reduced Lactobacillus diversity were associated with intrapartum fever. These results better defined relationships between the presence or absence of intrapartum fever, demographics, peripartum course, and vaginal microbial topics, and expanded our understanding of the impact of the microbiome on maternal and potentially neonatal outcome risk., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
13. What's to Be Done About Laboratory Quality? Process Indicators, Laboratory Stewardship, the Outcomes Problem, Risk Assessment, and Economic Value: Responding to Contemporary Global Challenges.
- Author
-
Meier FA, Badrick TC, and Sikaris KA
- Subjects
- Benchmarking, Clinical Laboratory Services economics, Cost-Benefit Analysis, Global Health, Humans, Outcome and Process Assessment, Health Care, Patient Safety standards, Quality Indicators, Health Care, Risk Assessment, Clinical Laboratory Services standards, Quality Assurance, Health Care
- Abstract
Objectives: For 50 years, structure, process, and outcomes measures have assessed health care quality. For clinical laboratories, structural quality has generally been assessed by inspection. For assessing process, quality indicators (QIs), statistical monitors of steps in the clinical laboratory total testing, have proliferated across the globe. Connections between structural and process laboratory measures and patient outcomes, however, have rarely been demonstrated., Methods: To inform further development of clinical laboratory quality systems, we conducted a selective but worldwide review of publications on clinical laboratory quality assessment., Results: Some QIs, like seven generic College of American Pathologists Q-Tracks monitors, have demonstrated significant process improvement; other measures have uncovered critical opportunities to improve test selection and result management. The College of Pathologists of Australasia Key Indicator Monitoring and Management System has deployed risk calculations, introduced from failure mode effects analysis, as surrogate measures for outcomes. Showing economic value from clinical laboratory testing quality is a challenge., Conclusions: Clinical laboratories should converge on fewer (7-14) rather than more (21-35) process monitors; monitors should cover all steps of the testing process under laboratory control and include especially high-risk specimen-quality QIs. Clinical laboratory stewardship, the combination of education interventions among clinician test orderers and report consumers with revision of test order formats and result reporting schemes, improves test ordering, but improving result reception is more difficult. Risk calculation reorders the importance of quality monitors by balancing three probabilities: defect frequency, weight of potential harm, and detection difficulty. The triple approach of (1) a more focused suite of generic consensus quality indicators, (2) more active clinical laboratory testing stewardship, and (3) integration of formal risk assessment, rather than competing with economic value, enhances it.
- Published
- 2018
- Full Text
- View/download PDF
14. Interpretive Diagnostic Error Reduction in Surgical Pathology and Cytology: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center and the Association of Directors of Anatomic and Surgical Pathology.
- Author
-
Nakhleh RE, Nosé V, Colasacco C, Fatheree LA, Lillemoe TJ, McCrory DC, Meier FA, Otis CN, Owens SR, Raab SS, Turner RR, Ventura CB, and Renshaw AA
- Subjects
- Humans, Laboratories standards, Systematic Reviews as Topic, Cytodiagnosis standards, Diagnostic Errors prevention & control, Pathology, Surgical standards
- Abstract
Context: Additional reviews of diagnostic surgical and cytology cases have been shown to detect diagnostic discrepancies., Objective: To develop, through a systematic review of the literature, recommendations for the review of pathology cases to detect or prevent interpretive diagnostic errors., Design: The College of American Pathologists Pathology and Laboratory Quality Center in association with the Association of Directors of Anatomic and Surgical Pathology convened an expert panel to develop an evidence-based guideline to help define the role of case reviews in surgical pathology and cytology. A literature search was conducted to gather data on the review of cases in surgical pathology and cytology., Results: The panel drafted 5 recommendations, with strong agreement from open comment period participants ranging from 87% to 93%. The recommendations are: (1) anatomic pathologists should develop procedures for the review of selected pathology cases to detect disagreements and potential interpretive errors; (2) anatomic pathologists should perform case reviews in a timely manner to avoid having a negative impact on patient care; (3) anatomic pathologists should have documented case review procedures that are relevant to their practice setting; (4) anatomic pathologists should continuously monitor and document the results of case reviews; and (5) if pathology case reviews show poor agreement within a defined case type, anatomic pathologists should take steps to improve agreement., Conclusions: Evidence exists that case reviews detect errors; therefore, the expert panel recommends that anatomic pathologists develop procedures for the review of pathology cases to detect disagreements and potential interpretive errors, in order to improve the quality of patient care.
- Published
- 2016
- Full Text
- View/download PDF
15. Assessing Clinical Laboratory Quality: A College of American Pathologists Q-Probes Study of Prothrombin Time INR Structures, Processes, and Outcomes in 98 Laboratories.
- Author
-
Howanitz PJ, Darcy TP, Meier FA, and Bashleben CP
- Subjects
- Anticoagulants adverse effects, Clinical Laboratory Services standards, Humans, Laboratory Proficiency Testing standards, Pathology, Clinical standards, Quality Control, Reference Standards, Societies, Medical, United States, Warfarin adverse effects, International Normalized Ratio standards, Laboratories standards, Prothrombin Time standards
- Abstract
Context: The anticoagulant warfarin has been identified as the second most frequent drug responsible for serious, disabling, and fatal adverse drug events in the United States, and its effect on blood coagulation is monitored by the laboratory test called international normalized ratio (INR)., Objective: To determine the presence of INR policies and procedures, INR practices, and completeness and timeliness of reporting critical INR results in participants' clinical laboratories., Design: Participants reviewed their INR policies and procedure requirements, identified their practices by using a questionnaire, and studied completeness of documentation and timeliness of reporting critical value INR results for outpatients and emergency department patients., Results: In 98 participating institutions, the 5 required policies and procedures were in place in 93% to 99% of clinical laboratories. Fifteen options for the allowable variations among duplicate results from different analyzers, 12 different timeliness goals for reporting critical values, and 18 unique critical value limits were used by participants. All required documentation elements were present in 94.8% of 192 reviewed INR validation reports. Critical value INR results were reported within the time frame established by the laboratory for 93.4% of 2604 results, but 1.0% of results were not reported. Although the median laboratories successfully communicated all critical results within their established time frames and had all the required validation elements based in their 2 most recent INR calculations, those participants at the lowest 10th percentile were successful in 80.0% and 85.7% of these requirements, respectively., Conclusions: Significant opportunities exist for adherence to INR procedural requirements and for practice patterns and timeliness goals for INR critical results' reporting.
- Published
- 2015
- Full Text
- View/download PDF
16. Practices for Identifying and Rejecting Hemolyzed Specimens Are Highly Variable in Clinical Laboratories.
- Author
-
Howanitz PJ, Lehman CM, Jones BA, Meier FA, and Horowitz GL
- Subjects
- Humans, Reproducibility of Results, Surveys and Questionnaires, Blood Chemical Analysis standards, Clinical Laboratory Services standards, Hemolysis, Laboratories, Hospital standards
- Abstract
Context: Hemolysis is an important clinical laboratory quality attribute that influences result reliability., Objective: To determine hemolysis identification and rejection practices occurring in clinical laboratories., Design: We used the College of American Pathologists Survey program to distribute a Q-Probes-type questionnaire about hemolysis practices to Chemistry Survey participants., Results: Of 3495 participants sent the questionnaire, 846 (24%) responded. In 71% of 772 laboratories, the hemolysis rate was less than 3.0%, whereas in 5%, it was 6.0% or greater. A visual scale, an instrument scale, and combination of visual and instrument scales were used to identify hemolysis in 48%, 11%, and 41% of laboratories, respectively. A picture of the hemolysis level was used as an aid to technologists' visual interpretation of hemolysis levels in 40% of laboratories. In 7.0% of laboratories, all hemolyzed specimens were rejected; in 4% of laboratories, no hemolyzed specimens were rejected; and in 88% of laboratories, some specimens were rejected depending on hemolysis levels. Participants used 69 different terms to describe hemolysis scales, with 21 terms used in more than 10 laboratories. Slight and moderate were the terms used most commonly. Of 16 different cutoffs used to reject hemolyzed specimens, moderate was the most common, occurring in 30% of laboratories. For whole blood electrolyte measurements performed in 86 laboratories, 57% did not evaluate the presence of hemolysis, but for those that did, the most common practice in 21 laboratories (24%) was centrifuging and visually determining the presence of hemolysis in all specimens., Conclusions: Hemolysis practices vary widely. Standard assessment and consistent reporting are the first steps in reducing interlaboratory variability among results.
- Published
- 2015
- Full Text
- View/download PDF
17. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
- Author
-
Kryvenko ON, Epstein JI, Meier FA, Gupta NS, Menon M, and Diaz M
- Subjects
- Adult, Aged, Aged, 80 and over, Body Mass Index, Humans, Male, Middle Aged, Nomograms, Obesity blood, Overweight blood, Overweight complications, Prostatectomy, Prostatic Neoplasms blood, Prostatic Neoplasms surgery, Obesity complications, Prostate-Specific Antigen blood, Prostatic Neoplasms pathology
- Abstract
Objectives: Prostate cancer screening algorithms and preoperative nomograms do not include patients' body mass index (BMI). We evaluated outcomes at radical prostatectomy (RP) adjusted to BMI., Methods: Serum prostate-specific antigen (PSA) levels, PSA mass, PSA density (PSAD), and RP findings were analyzed with respect to BMI in 4,926 men who underwent RP between 2005 and 2014., Results: In total, 1,001 (20.3%) men were normal weight, 2,547 (51.7%) were overweight, and 1,378 (28%) were obese. Median PSA levels (ng/mL) were normal weight, 5.0; overweight, 5.1; and obese, 5.2 (P = .094). Median PSA mass increased with increasing BMI: 15.9 vs 17.4 vs 19.4 μg (P < .001). Median PSAD was not significantly different: 0.11 vs 0.11 vs 0.11 ng/mL/g (P = .084). Median prostate weight increased with increasing BMI: 44 vs 45 vs 49 g (P < .001). Median prostatectomy tumor volume increased with increasing BMI: 3.9 vs 4.7 vs 5.9 cm(3) (P < .001). Overweight and obese patients had a higher Gleason score and more locally advanced cancer (P < .001). Frequency of positive surgical margins increased with higher BMIs (P < .001). Frequency of lymph node metastasis did not differ significantly (P = .088)., Conclusions: While BMI correlates with tumor volume, Gleason score, and extent of disease at RP, there is no routinely measured clinical parameter reflecting this. Only PSA mass highlights this correlation. Thus, BMI and potentially PSA mass should be taken into account in predictive algorithms pertaining to prostate cancer and its surgical treatment., (Copyright© by the American Society for Clinical Pathology.)
- Published
- 2015
- Full Text
- View/download PDF
18. Clinical Laboratory Quality Practices When Hemolysis Occurs.
- Author
-
Howanitz PJ, Lehman CM, Jones BA, Meier FA, and Horowitz GL
- Subjects
- Humans, Laboratories economics, Quality Control, Quality of Health Care, Health Care Costs, Hemolysis, Laboratories standards
- Abstract
Context: Hemolyzed specimens delay clinical laboratory results, proliferate unnecessary testing, complicate physician decisions, injure patients indirectly, and increase health care costs., Objective: To determine quality improvement practices when hemolysis occurs., Design: We used the College of American Pathologists (CAP) Survey Program to distribute a Q-Probes-type questionnaire about hemolysis practices to CAP Chemistry Survey participants., Results: Of 3495 participants sent the questionnaire, 846 (24%) responded. Although 85%, 69%, and 55% of participants had written hemolysis policies for potassium, lactate dehydrogenase, and glucose, respectively, only a few (46%, 40%, and 40%) had standardized hemolysis reports between their primary and secondary chemistry analyzers for these 3 analytes. Most participants (70%) had not attempted to validate the manufacturers' hemolysis data for these 3 analytes; however, essentially all who tried, succeeded. Forty-nine percent of participants had taken corrective action to reduce hemolysis during the past year and used, on average, 2.4 different actions, with collection and distribution of hemolysis data to administrative leadership (57%), troubleshooting outliers (55%), retraining phlebotomist (53%), and establishment of quality improvement teams among the laboratory and at problem locations (37%) being the most common actions. When asked to assess their progress in reducing hemolysis, 70% noted slow to no progress, and 2% gave up on improvement. Upon measuring potassium, lactate dehydrogenase, and glucose, approximately 60% of participants used the same specimen flag for hemolysis as for lipemia and icterus., Conclusions: Hemolysis decreases the quality and increases the cost of health care. Practices for measuring, reporting, and decreasing hemolysis rates need improvement.
- Published
- 2015
- Full Text
- View/download PDF
19. Seven Q-Tracks monitors of laboratory quality drive general performance improvement: experience from the College of American Pathologists Q-Tracks program 1999-2011.
- Author
-
Meier FA, Souers RJ, Howanitz PJ, Tworek JA, Perrotta PL, Nakhleh RE, Karcher DS, Bashleben C, Darcy TP, Schifman RB, and Jones BA
- Subjects
- Clinical Laboratory Techniques standards, Humans, Laboratory Proficiency Testing standards, Laboratory Proficiency Testing trends, Pathology, Clinical organization & administration, Pathology, Clinical standards, Quality Assurance, Health Care standards, Quality Assurance, Health Care trends, Reproducibility of Results, Societies, Medical, United States, Clinical Laboratory Techniques methods, Laboratory Proficiency Testing methods, Pathology, Clinical methods, Quality Assurance, Health Care methods
- Abstract
Context: Many production systems employ standardized statistical monitors that measure defect rates and cycle times, as indices of performance quality. Clinical laboratory testing, a system that produces test results, is amenable to such monitoring., Objective: To demonstrate patterns in clinical laboratory testing defect rates and cycle time using 7 College of American Pathologists Q-Tracks program monitors., Design: Subscribers measured monthly rates of outpatient order-entry errors, identification band defects, and specimen rejections; median troponin order-to-report cycle times and rates of STAT test receipt-to-report turnaround time outliers; and critical values reporting event defects, and corrected reports. From these submissions Q-Tracks program staff produced quarterly and annual reports. These charted each subscriber's performance relative to other participating laboratories and aggregate and subgroup performance over time, dividing participants into best and median performers and performers with the most room to improve. Each monitor's patterns of change present percentile distributions of subscribers' performance in relation to monitoring durations and numbers of participating subscribers. Changes over time in defect frequencies and the cycle duration quantify effects on performance of monitor participation., Results: All monitors showed significant decreases in defect rates as the 7 monitors ran variously for 6, 6, 7, 11, 12, 13, and 13 years. The most striking decreases occurred among performers who initially had the most room to improve and among subscribers who participated the longest. All 7 monitors registered significant improvement. Participation effects improved between 0.85% and 5.1% per quarter of participation., Conclusions: Using statistical quality measures, collecting data monthly, and receiving reports quarterly and yearly, subscribers to a comparative monitoring program documented significant decreases in defect rates and shortening of a cycle time for 6 to 13 years in all 7 ongoing clinical laboratory quality monitors.
- Published
- 2015
- Full Text
- View/download PDF
20. Timeliness and accuracy of reporting preliminary blood culture results: a College of American Pathologists Q-probes study of 65 institutions.
- Author
-
Schifman RB, Meier FA, and Souers RJ
- Subjects
- Blood Specimen Collection, Gentian Violet, Humans, Phenazines, Quality Assurance, Health Care, Research Design statistics & numerical data, Societies, Medical, Time Factors, United States, Bacteremia microbiology, Benchmarking standards, Laboratories standards, Medical Records standards, Pathology, Clinical standards, Research Design standards
- Abstract
Context: The speed and accuracy of preliminary blood culture reports impacts patient management and outcomes., Objective: To evaluate the accuracy and timeliness of preliminary blood culture results among multiple laboratories., Design: Q-Probes participants collected turnaround time (TAT) data on preliminary Gram stains, compared accuracy of up to 100 preliminary to final culture Gram stain results, and described blood culture laboratory practices., Results: Sixty-four laboratories and 5031 blood cultures were evaluated. All participants used continuously monitoring blood culture systems. Median TAT from initial growth detection to notification of results was 45 minutes, with the longest component being preparation of Gram stains (median time = 25 minutes). Participants (N = 40) reporting a continuous schedule for processing blood cultures had significantly lower overall TAT (median= 37 minutes) compared with 15 participants with intermittent processing schedules (median= 124 minutes), P= .003. Time to complete Gram stain processing was lower (median time = 21 minutes) for 39 participants using continuous processing schedule compared with 14 others (median time= 67 minutes), P= .03. Goals for total TAT were used by 27 of 56 participants (48.2%). Having goals did not significantly affect TAT. A total of 4962 of 5021 Gram stain results (98.8%) agreed with final culture results. The highest discrepancy rates occurred among gram-positive bacilli (20 of 335; 6.0%) and mixed cultures (22 of 106; 20.8%)., Conclusions: This study provides benchmarks for assessing blood culture quality performance. Timeliness and accuracy of preliminary blood culture reports were excellent. However, nearly one-third of laboratories did not process blood cultures continuously. This significantly prolonged reporting results, which could affect patient outcomes.
- Published
- 2015
- Full Text
- View/download PDF
21. Twenty-five years of accomplishments of the College of American Pathologists Q-probes program for clinical pathology.
- Author
-
Howanitz PJ, Perrotta PL, Bashleben CP, Meier FA, Ramsey GE, Massie LW, Zimmerman RL, and Karcher DS
- Subjects
- Certification, History, 20th Century, History, 21st Century, Humans, Laboratories standards, Pathology, Clinical standards, Professional Competence, Quality Assurance, Health Care history, Societies, Medical, United States, Laboratories history, Pathology, Clinical history
- Abstract
Context: During the past 25 years, the College of American Pathologists' (CAP) Q-Probes program has been available as a subscription program to teach laboratorians how to improve the quality of clinical laboratory services., Objective: To determine the accomplishments of the CAP Q-Probes program., Design: We reviewed Q-Probes participant information, study data and conclusions, author information, and program accomplishments., Results: During this time 117 Q-Probes clinical pathology studies were conducted by 54 authors and coauthors, 42,899 laboratories enrolled from 24 countries, 98 peer-reviewed publications occurred and were cited more than 1600 times, and the studies were featured 59 times in CAP Today. The most frequent studies (19) focused on turnaround times for results or products at specific locations (emergency department, operating room, inpatients, outpatients), specific diseases (acute myocardial infarction, urinary tract), availability for specific events such as morning rounds or surgery, a specific result (positive blood cultures), and a method on how to use data for improvement (stat test outliers). Percentile ranking of study participants with better performance provided benchmarks for each study with attributes statistically defined that influenced improved performance. Other programs, such as an ongoing quality improvement program (Q-Tracks), a laboratory competency assessment program, a pathologist certification program, and an ongoing physician practice evaluation program (Evalumetrics), have been developed from Q-Probes studies., Conclusions: The CAP's Q-Probes program has made significant contributions to the medical literature and has developed a worldwide reputation for improving the quality of clinical pathology services worldwide.
- Published
- 2014
- Full Text
- View/download PDF
22. Fifteen years' experience of a College of American Pathologists program for continuous monitoring and improvement.
- Author
-
Nakhleh RE, Souers RJ, Bashleben CP, Talbert ML, Karcher DS, Meier FA, and Howanitz PJ
- Subjects
- History, 20th Century, History, 21st Century, Humans, Laboratories standards, Pathology, Clinical standards, Retrospective Studies, Societies, Medical, United States, Laboratories history, Pathology, Clinical history, Quality Assurance, Health Care history
- Abstract
Context: The Q-Tracks program, created in 1999, is a quality monitoring subscription service offered by the College of American Pathologists., Objective: To establish benchmarks in quality metrics, monitor changes in performance over time, and identify practice characteristics associated with better performance., Design: The Q-Tracks program provides ongoing study of multiple metrics offered in most laboratory disciplines. The design enables measuring the effects of process changes and comparisons with other participating laboratories. Each laboratory Q-Tracks monitor has a primary quality indicator and additional secondary indicators., Results: To date, 19 Q-Tracks monitors have been offered, with 12 currently active monitors. Q-Tracks are primarily conducted in hospital-based laboratories in the United States, Canada, and 21 other countries. Common to most Q-Tracks monitors is a demonstration of performance improvement by subscribers with long-term participation. This finding was seen in preanalytic, turnaround time, and postanalytic measures. Q-Tracks monitors contribute to the overall demonstration and improvement of laboratory and hospital quality because they address core quality measures for the College of American Pathologists Laboratory Accreditation Program and multiple Joint Commission National Patient Safety Goals., Conclusions: The Q-Tracks program has established multiple benchmarks in most disciplines of the laboratory and has demonstrated significant performance improvement in benchmarks and individual laboratories over time.
- Published
- 2014
- Full Text
- View/download PDF
23. Do not assume. Information flow and the electronic medical record.
- Author
-
Meier FA
- Subjects
- Humans, Medical Records, Pathology, Surgical, Practice Patterns, Physicians', Referral and Consultation
- Published
- 2014
- Full Text
- View/download PDF
24. Surgical pathology report defects: a College of American Pathologists Q-Probes study of 73 institutions.
- Author
-
Volmar KE, Idowu MO, Hunt JL, Souers RJ, Meier FA, and Nakhleh RE
- Subjects
- Benchmarking classification, Communication, Humans, Pathology, Surgical classification, Prospective Studies, Quality Assurance, Health Care classification, Quality Control, Quality of Health Care classification, Quality of Health Care standards, Terminology as Topic, Benchmarking standards, Pathology, Surgical standards, Quality Assurance, Health Care standards, Research Design standards
- Abstract
Context: The rate of surgical pathology report defects is an indicator of quality and it affects clinician satisfaction., Objective: To establish benchmarks for defect rates and defect fractions through a large, multi-institutional prospective application of standard taxonomy., Design: Participants in a 2011 Q-Probes study of the College of American Pathologists prospectively reviewed all surgical pathology reports that underwent changes to correct defects and reported details regarding the defects., Results: Seventy-three institutions reported 1688 report defects discovered in 360,218 accessioned cases, for an aggregate defect rate of 4.7 per 1000 cases. Median institutional defect rate was 5.7 per 1000 (10th to 90th percentile range, 13.5-0.9). Defect rates were higher in institutions with a pathology training program (8.5 versus 5.0 per 1000, P = .01) and when a set percentage of cases were reviewed after sign-out (median, 6.7 versus 3.8 per 1000, P = .10). Defect types were as follows: 14.6% misinterpretations, 13.3% misidentifications, 13.7% specimen defects, and 58.4% other report defects. Overall, defects were most often detected by pathologists (47.4%), followed by clinicians (22.0%). Misinterpretations and specimen defects were most often detected by pathologists (73.5% and 82.7% respectively, P < .001), while misidentifications were most often discovered by clinicians (44.6%, P < .001). Misidentification rates were lower when all malignancies were reviewed by a second pathologist before sign-out (0.0 versus 0.6 per 1000, P < .001), and specimen defect rates were lower when intradepartmental review of difficult cases was conducted after sign-out (0.0 versus 0.4 per 1000, P = .02)., Conclusion: This study provides benchmarking data on report defects and defect fractions using standardized taxonomy.
- Published
- 2014
- Full Text
- View/download PDF
25. Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases.
- Author
-
Kryvenko ON, Chitale DA, Yoon J, Arias-Stella J 3rd, Meier FA, and Lee MW
- Subjects
- Adenocarcinoma, Mucinous metabolism, Adult, Aged, Aged, 80 and over, Biomarkers, Tumor metabolism, Breast Neoplasms, Male metabolism, Carcinoma, Intraductal, Noninfiltrating metabolism, Female, Humans, Ki-67 Antigen metabolism, Male, Middle Aged, Mucins metabolism, Precancerous Conditions metabolism, Adenocarcinoma, Mucinous pathology, Breast Neoplasms, Male pathology, Carcinoma, Intraductal, Noninfiltrating pathology, Cell Transformation, Neoplastic, Precancerous Conditions pathology
- Abstract
Mucinous mammary carcinoma (MC) is a tumor type with relatively favorable prognosis. Unlike the circumstances surrounding conventional invasive duct carcinoma, data are limited regarding precursor lesions for MC. This study characterizes patterns of mucinous ductal carcinoma in situ (DCIS) as a precursor lesion for MC. All slides from 130 cases of MC encountered between 2000 and 2011 at Henry Ford Hospital, Detroit, MI were reviewed to subclassify MC, identify DCIS, and explore transition patterns from DCIS to MC. Calponin, p63, chromogranin, synaptophysin, CD56, and MIB-1 immunostaining analyses were performed in 65 cases. Among 106 cases of pure (71 type A, 35 type B) and 24 cases of mixed MC, DCIS appeared in 88 (68%) specimens, with all but 4 showing luminal mucin accumulation. Dominant patterns of mucinous DCIS were cribriform/solid (66), cribriform and papillary (7), papillary (5), micropapillary (3), and flat (3). Fifty-seven (68%) cases of mucinous DCIS demonstrated transitions from DCIS to MC. Luminal mucinous distention, focal flattening and attenuation of the epithelium, and disruption of the duct wall resulting in a mucocele-like extravasation of malignant epithelia with escaping mucin was a transition pattern seen with all architectures of DCIS and in all types of MC. This was the only pattern of transition to type A MC. The epithelial outpouching, formation of a cleft with accumulation of mucin around the epithelium, and transition into mucin pools with floating tumor cell clusters was the second transition pattern that went from cribriform/solid DCIS to type B and mixed MC. DCIS preceding aggressive phenotypes of MC (type B and mixed) more often had a cribriform/solid architecture, higher nuclear grade, and higher Ki-67-labeling index (all P<0.05). In summary, mucinous DCIS is a precursor to MC with distinctive features that link patterns of DCIS with aggressive MC phenotypes. The 2 observed transitions between mucinous DCIS and MC suggest that pathogenesis of different types of MC is different correlating with less or more aggressive behavior of the latter.
- Published
- 2013
- Full Text
- View/download PDF
26. Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures.
- Author
-
Samuel LP, Tibbetts RJ, Agotesku A, Fey M, Hensley R, and Meier FA
- Subjects
- Bacteremia microbiology, Genes, Bacterial, Gram-Positive Bacteria isolation & purification, Gram-Positive Bacterial Infections microbiology, Humans, Time Factors, Bacteremia diagnosis, Bacteriological Techniques methods, Drug Resistance, Bacterial, Gram-Positive Bacteria drug effects, Gram-Positive Bacterial Infections diagnosis, Microarray Analysis methods, Molecular Diagnostic Techniques methods
- Abstract
Rapid identification of pathogens directly from positive blood cultures can play a major role in reducing patient mortality rates. We evaluated the performance of the Verigene Gram-Positive Blood Culture (BC-GP) assay (Nanosphere Inc., Northbrook, IL) for detection of commonly isolated Gram-positive organisms as well as associated resistance markers from positive blood cultures. Positive blood cultures (VersaTREK; Trek Diagnostic Systems, Independence, OH) from 203 patients with Gram-positive organism infections were analyzed using the BC-GP assay within 12 h for the detection of 12 different organisms, including staphylococci, streptococci, and enterococci, as well as for the presence of 3 resistance markers (mecA, vanA, and vanB). Results were compared to those of routine laboratory methods for identification and susceptibility testing. For identification of organisms and detection of resistance markers in 178 monomicrobial positive blood cultures, the BC-GP assay showed 94% and 97% concordance, respectively, with routine methods. After 25 polymicrobial cultures were included, the results showed 92% and 96% agreement for identification and resistance markers, respectively, for a total of 203 positive cultures. In 6/25 polymicrobial cultures, at least 1 isolate was not detected. Concordance levels for detection of major pathogens such Staphylococcus aureus (n = 45) and enterococci (n = 19) were 98% and 95%, respectively. Agreement levels for detection of resistance markers such as mecA and vanA/B were 92% and 100%, respectively. The BC-GP assay is capable of providing rapid identification of Gram-positive cocci as well as detection of resistance markers directly from positive blood cultures at least 24 to 48 h earlier than conventional methods.
- Published
- 2013
- Full Text
- View/download PDF
27. Discordant Streptococcus agalactiae (Group B streptococcus) gestational infection in monochorionic/diamniotic and dichorionic/diamniotic twins.
- Author
-
Pimentel JD, Szymanski LJ, Samuel LP, and Meier FA
- Subjects
- Adult, Chorion, Female, Humans, Pregnancy, Stillbirth, Streptococcus agalactiae, Pregnancy Complications, Infectious, Streptococcal Infections complications, Twins
- Abstract
Infection due to Streptococcus agalactiae or Group B streptococcus may be acquired during parturition or gestation. Discordant twin gestational Group B streptococcus infections are rarely reported. We describe two cases of fatal discordant gestational Group B streptococcus infection in both a monochorionic/diamniotic pregnancy and in a dichorionic/diamniotic pregnancy. In both instances, cultures, examination of the placentae, and autopsy findings demonstrated infection by Group B streptococcus in only the presenting fetus. Despite the ubiquity of this organism, this is the first documented case of discordant gestational Group B streptococcus infection in monochorionic/diamniotic twins and only the third case documented in dichorionic/diamniotic twins.
- Published
- 2012
- Full Text
- View/download PDF
28. Staffing benchmarks for clinical laboratories: a College of American Pathologists Q-Probes study of laboratory staffing at 98 institutions.
- Author
-
Jones BA, Darcy T, Souers RJ, and Meier FA
- Subjects
- Quality Improvement, Benchmarking, Laboratories organization & administration, Medical Laboratory Personnel organization & administration, Pathology, Clinical organization & administration, Personnel Staffing and Scheduling organization & administration
- Abstract
Context: Publicly available information concerning laboratory staffing benchmarks is scarce. One of the few publications on this topic summarized the findings of a Q-Probes study performed in 2004. This publication reports a similar survey with data collected in 2010., Objective: To assess the relationship between staffing levels in specified laboratory sections and test volumes in these sections and quantify management span of control., Design: The study defined 4 laboratory sections: anatomic pathology (including cytology), chemistry/hematology/immunology, microbiology, and transfusion medicine. It divided staff into 3 categories: management, nonmanagement (operational or bench staff), and doctoral (MD, PhD) supervisory staff. People in these categories were tabulated as full-time equivalents and exclusions specified. Tests were counted in uniform formats, specified for each laboratory section, according to Medicare rules for the bundling and unbundling of tests., Results: Ninety-eight participating institutions provided data that showed significant associations between test volumes and staffing for all 4 sections. There was wide variation in productivity based on volume. There was no relationship between testing volume per laboratory section and management span of control. Higher productivity in chemistry/hematology/immunology was associated with a higher fraction of tests coming from nonacute care patients. In both the 2004 and 2010 studies, productivity was inseparably linked to test volume., Conclusions: Higher test volume was associated with higher productivity ratios in chemistry/hematology/immunology and transfusion medicine sections. The impact of various testing services on productivity is section-specific.
- Published
- 2012
- Full Text
- View/download PDF
29. Comparison of time to positivity of the VersaTREK® REDOX 80-mL and the REDOX EZ draw 40-mL blood culture bottles for common bacterial bloodstream pathogens.
- Author
-
Samuel LP, Pimentel JD, Tibbetts RJ, Martin R, Hensley R, and Meier FA
- Subjects
- Aerobiosis, Anaerobiosis, Bacteremia diagnosis, Bacteria growth & development, Culture Media, Humans, Reagent Kits, Diagnostic, Bacteremia microbiology, Bacteria isolation & purification, Bacteriological Techniques, Blood microbiology
- Abstract
The VersaTREK(®) microbial detection system offers 2 media formulations, an aerobic and an anaerobic bottle available in a 40-mL direct draw format and an 80-mL format. The 40-mL EZ Draw(®) bottle can be inoculated with a maximum volume of 5 mL, while the REDOX 80-mL bottle accommodates a 10-mL volume. The effect of volume of blood inoculum on time to positivity (TTP) has not been clearly established with these bottle types. This study utilized simulated blood cultures seeded with clinically relevant microorganisms in human blood to evaluate the impact of inoculum volume and organism load on TTP for the 2 bottle types. For 13/15 organisms, the EZ Draw bottle flagged positive earlier than the REDOX 80-mL bottles. The lower volume of blood inoculum did not negatively impact TTP using the EZ Draw blood culture bottles as compared to REDOX 80-mL bottles., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
30. Study of amended reports to evaluate and improve surgical pathology processes.
- Author
-
Meier FA, Varney RC, and Zarbo RJ
- Subjects
- Data Collection, Diagnostic Errors classification, Humans, Pathology, Surgical standards, Patient Identification Systems, Quality Control, Specimen Handling, Total Quality Management, Diagnostic Errors prevention & control, Medical Records, Outcome and Process Assessment, Health Care, Pathology, Surgical methods
- Abstract
Background: : Amended surgical pathology reports record defects in the process of transforming tissue specimens into diagnostic information., Objective: : Systematic study of amended reports tests 2 hypotheses: (a) that tracking amendment frequencies and the distribution of amendment types reveals relevant aspects of quality in surgical pathology's daily transformation of specimens into diagnoses and (b) that such tracking measures the effect, or lack of effect, of efforts to improve surgical pathology processes., Materials and Methods: : We applied a binary definition of altered reports as either amendments or addenda and a taxonomy of defects that caused amendments as misidentifications, specimen defects, misinterpretations, and report defects. During the introduction of a LEAN process improvement approach-the Henry Ford Productions System-we followed trends in amendment rates and defect fractions to (a) evaluate specific interventions, (b) sort case-by-case root causes of misidentifications, specimen defects, and misinterpretations, and (c) audit the ongoing accuracy of the classification of changed reports. LEAN is the management and production system of the Toyota Motor Corporation that promotes continuous improvement; it considers wasted resources expended for purposes other than creating value for end customers and targets such expenditures for elimination., Results: : Introduction of real-time editing of amendments saw annual amendment rates increase from 4.8/1000 to 10.1/1000 and then decrease in an incremental manner to 5.6/1000 as Henry Ford Productions System-specific interventions were introduced. Before introduction of HFPS interventions, about a fifth of the amendments were due to misidentifications, a 10th were due to specimen defects, a quarter due to misinterpretation, and almost half were due to report defects. During the period of the initial application of HFPS, the fraction of amendments due to misidentifications decreased as those due to report defects increased, in a statistically linked manner. As HFPS interventions took hold, misidentifications fell from 16% to 9%, specimen defect rates remained variable, ranging between 2% and 11%, and misinterpretations fell from 18% to 3%. Reciprocally, report defects rose from 64% to 83% of all amendment-causing defects. A case-by-case study of misidentifications, specimen defects, and misinterpretations found that (a) intervention at the specimen collection level had disappointingly little effect on patient misidentifications; (b) standardization of specimen accession and gross examination reduced only specimen defects surrounding ancillary testing; but (c) a double review of breast and prostate cases was associated with drastically reduced misinterpretation defects. Finally, audit of both amendments and addenda demonstrated that 10% of the so-called addenda actually qualified as amendments., Discussion: : Monitored by the consistent taxonomy, rates of amended reports first rose, then fell. Examining specific defect categories provided information for evaluating specific LEAN interventions. Tracking the downward trend of amendment rates seemed to document the overall success of surgical pathology quality improvement efforts. Process improvements modestly decreased fractions of misidentifications and markedly decreased misinterpretation fractions. Classification integrity requires real time, independent editing of both amendments (changed reports) and addenda (addition to reports).
- Published
- 2011
- Full Text
- View/download PDF
31. Anastomosing hemangioma of the genitourinary system: eight cases in the kidney and ovary with immunohistochemical and ultrastructural analysis.
- Author
-
Kryvenko ON, Gupta NS, Meier FA, Lee MW, and Epstein JI
- Subjects
- Adult, Aged, Biomarkers, Tumor metabolism, Female, Hemangioma diagnostic imaging, Hemangioma metabolism, Humans, Kidney Neoplasms diagnostic imaging, Kidney Neoplasms metabolism, Male, Middle Aged, Ovarian Neoplasms diagnostic imaging, Ovarian Neoplasms metabolism, Ultrasonography, Hemangioma diagnosis, Kidney Neoplasms diagnosis, Ovarian Neoplasms diagnosis
- Abstract
We describe 3 ovarian and 5 renal anastomosing hemangiomas. One manifested with polycythemia, others were incidental; none recurred. The mean patient age was 58 years. Three hemangiomas developed in end-stage renal disease. Tumors were well-demarcated, mahogany brown, spongy lesions measuring 0.1 to 5 cm. Tortuous large vessels fed and drained tightly packed anastomosing sinusoidal capillary channels. Four hemangiomas exhibited lobular architecture, central edema/hyalinization, and intravascular growth. Five cases had thrombosis, hemorrhage, and hemosiderin. One ovarian tumor induced stromal luteinization. Three tumors had foci of extramedullary hematopoiesis (one associated with polycythemia). Six cases demonstrated eosinophilic intracytoplasmic globules. Three cases included hobnail endothelial cells. Atypia was minimal and mitoses were absent in all cases. We find this vascular neoplasm unique for the genitourinary system. Despite selected features mimicking angiosarcoma, our data support its benign nature. The current study expands the gross and radiographic appearance, clinical aspects, and ultrastructure, with the first report of the lesion occurring in the ovary.
- Published
- 2011
- Full Text
- View/download PDF
32. Mislabeling of cases, specimens, blocks, and slides: a college of american pathologists study of 136 institutions.
- Author
-
Nakhleh RE, Idowu MO, Souers RJ, Meier FA, and Bekeris LG
- Subjects
- Humans, Quality Assurance, Health Care, Reproducibility of Results, Societies, Medical, United States, Laboratories, Hospital standards, Medical Records standards, Pathology, Surgical standards, Specimen Handling standards
- Abstract
Context: Accurate specimen labeling is a major patient-safety initiative by the Joint Commission and the College of American Pathologists. Inadequate specimen labels have led to patient injury from wrong patient diagnosis, wrong side treatment, and delay in diagnosis., Objectives: To quantify the rates of mislabeled cases, specimens, blocks, and slides and to identify the sources of error and the ways in which errors are detected., Design: In this voluntary-subscription Q-Probes study, participants prospectively reviewed surgical pathology cases for 8 weeks or until 30 errors (mislabeled cases, specimens, blocks, and slides) were identified. Information collected on each labeling error included the work location where the defect occurred, what was mislabeled, the number of items affected, the point of detection, and the consequences of the mislabeling error, along with institutional demographics and practice. The rates of mislabeled cases, specimens, blocks, and slides were tested for association with institutional demographics and practice variables., Results: Of the 136 institutions providing information on a total of 1811 mislabeling occurrences, the overall mislabeling rates per 1000 were 1.1 cases, 1.0 specimen, 1.7 blocks, and 1.1 slides. Of all mislabeling events, 27.1% were cases, 19.8% specimens, 25.5% blocks, and 27.7% slides. The work locations at which the errors occurred were 20.9% before accessioning, 12.4% at accessioning, 21.7% at block labeling, 10.2% during gross pathology, and 30.4% at tissue cutting. Errors were typically detected in the first or second steps immediately following the error. Lower mislabeled slide rates were associated with continuous individual case accessioning and use of formal checks at accessioning. Routinely including a statement in the gross description that the specimen is labeled with the patient's name and is properly identified was also associated with lower rates of specimen mislabeling. The errors were corrected before reports were issued 96.7% of the time; for 3.2% of errors, a corrected report was issued. In 1.3% of error occurrences, participants gauged that patient care was affected., Conclusions: This study quantified mislabeling rates across 136 institutions of cases (0.11%), specimens (0.1%), blocks (0.17%), and slides (0.11%). Errors in labeling appear nearly equally throughout the system of accessioning, gross pathology processing, and tissue cutting. Errors are typically detected in the immediate steps after the errors occurred, reinforcing the need for quality checks throughout the system.
- Published
- 2011
- Full Text
- View/download PDF
33. Chorioamnionitis and neonatal sepsis from community-associated MRSA.
- Author
-
Pimentel JD, Meier FA, and Samuel LP
- Subjects
- Adult, Female, Humans, Infant, Newborn, Pregnancy, Bacteremia etiology, Chorioamnionitis etiology, Methicillin-Resistant Staphylococcus aureus isolation & purification
- Published
- 2009
- Full Text
- View/download PDF
34. Eosinophilic globules in 3 cases of glomeruloid hemangioma of the head and neck: a characteristic offering more evidence for thanatosomes with or without POEMS.
- Author
-
Lee H, Meier FA, Ma CK, Ormsby AH, and Lee MW
- Subjects
- Aged, Antigens, CD34 metabolism, Female, Head and Neck Neoplasms blood supply, Head and Neck Neoplasms diagnosis, Hemangioma, Capillary blood supply, Hemangioma, Capillary diagnosis, Humans, Male, Middle Aged, Neovascularization, Pathologic, POEMS Syndrome complications, POEMS Syndrome diagnosis, Platelet Endothelial Cell Adhesion Molecule-1 metabolism, von Willebrand Factor metabolism, Eosinophils pathology, Head and Neck Neoplasms pathology, Hemangioma, Capillary pathology, Inclusion Bodies pathology, Lysosomes pathology, POEMS Syndrome pathology
- Abstract
Glomeruloid hemangiomas (GHs) are glomeruli-like capillary tufts lined by endothelial cells that contain periodic acid-Schiff (PAS) positive eosinophilic globules (EGs). These hemangiomas are characteristic cutaneous manifestation of POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin changes). Hemangiomas histologically identical to GHs but not associated with POEMS have recently been designated as papillary hemangiomas. In this report, we present solitary head and neck GHs in 3 patients, 2 without POEMS, with particular attention to the characteristic EGs. We performed immunostains for hemoglobin A, kappa and lambda light chains, factor VIII-related antigen, CD31 and CD34, PAS stain after diastase digestion (PASD), and electron microscopic examinations on routinely fixed tissues containing EGs. Eosinophilic globules stained uniformly positive for PASD but only peripherally positive for hemoglobin and light chains on surfaces, with interiors negative for antigens. Factor VIII-related antigen and CD31 and CD34 confirmed cells containing EGs to be endothelial. Electron microscopic examination suggested that EGs are enlarged secondary lysosomes (thanatosomes). These features fail to support red blood cells or immunoglobulins as EG constituents. Glomeruloid hemangiomas may be vascular proliferations stimulated by endothelial cells' protein phagocytosis but not by phagocytosis of either hemoglobin-containing red blood cells or immunoglobulins. The vascular lesions in POEMS syndrome appear identical to papillary hemangioma in cases without the other syndromic manifestations.
- Published
- 2008
- Full Text
- View/download PDF
35. Amended reports: development and validation of a taxonomy of defects.
- Author
-
Meier FA, Zarbo RJ, Varney RC, Bonsal M, Schultz DS, Vrbin CM, Grzybicki DM, and Raab SS
- Subjects
- Humans, Quality Control, Diagnostic Errors classification, Pathology, Clinical methods, Process Assessment, Health Care
- Abstract
Amended pathology reports produce rework, confusion, and distrust. To develop a reproducible amendment taxonomy we derived a classification from 141 amended reports, then validated it with 130 new cases before 4 observers independently reviewed 430 cases measuring agreement (k). Next, agreement in classifying 30 other amended reports in 7 institutions was measured. We further tracked amendment rates, defect categories, defect discoverers, and discovery mechanisms. In the 430-case validation set agreement was excellent (k = 0.8780 [range, 0.8416-0.9144]). Among the 7 institutions, agreement was good (k = 0.6235 [range, 0.3105-0.8975]). Amendment rates ranged from 2.6 to 4.8 per 1,000 reports. Misinterpretation fractions varied least (23%-29%). Misidentification fractions ranged more widely (20%-38%). Specimen defects were least frequent (4%-10%) and report defects most frequent (29%-48%). Misidentifications and report defects inversely correlated. Pathologists discovered most misinterpretations, and clinicians found most misidentifications. Conference review revealed 40% to 80% of misinterpretations. This taxonomy produced excellent reproducibility and good agreement across institutions.
- Published
- 2008
- Full Text
- View/download PDF
36. Anatomic pathology and patient safety: it's not an error: it's a diagnostic misadventure!
- Author
-
Grzybicki DM, Raab SS, Janosky JE, Vrbin-Turcsanyi C, Bruno S, Zarbo RJ, Stone CH, Meier FA, Geisinger KR, and Gavin AJ
- Subjects
- Clinical Competence, Humans, Safety, Diagnostic Errors prevention & control, Observer Variation, Pathology, Surgical standards, Patient Care standards, Quality Assurance, Health Care
- Published
- 2008
37. Frequency and outcome of cervical cancer prevention failures in the United States.
- Author
-
Raab SS, Grzybicki DM, Zarbo RJ, Jensen C, Geyer SJ, Janosky JE, Meier FA, Vrbin CM, Carter G, and Geisinger KR
- Subjects
- Colposcopy standards, Diagnostic Errors standards, Female, Humans, Mass Screening standards, Neoplasm Staging, Patient Care Management statistics & numerical data, Reproducibility of Results, Uterine Cervical Neoplasms prevention & control, Vaginal Smears standards, Colposcopy statistics & numerical data, Diagnostic Errors statistics & numerical data, Mass Screening statistics & numerical data, Papanicolaou Test, Predictive Value of Tests, Uterine Cervical Neoplasms diagnosis, Vaginal Smears statistics & numerical data
- Abstract
We measured the frequency and outcome of cervical cancer prevention failures that occurred in the Papanicolaou (Pap) and colposcopy testing phases involving 1,646,580 Pap tests in 4 American hospital systems between January 1, 1998, and December 31, 2004. We defined a screening failure as a 2-step or greater discordant Pap test result and follow-up biopsy diagnosis. A total of 5,278 failures were detected (0.321% of all Pap tests); 48% and 52% of failures occurred in the Pap test and colposcopy phases, respectively. Missed squamous cancers (1 in 187,786 Pap tests), glandular cancers (1 in 19,426 Pap tests), and high-grade lesions (1 in 6,870 Pap tests) constituted 4.1% of all failures. Unnecessary repeated tests or diagnostic delays occurred in 70.8% and 63.9% of failures involving high- and low-grade lesions, respectively. We conclude that cervical cancer prevention practices are remarkably successful in preventing squamous cancers, although a high frequency of failures results in low-impact negative outcomes.
- Published
- 2007
- Full Text
- View/download PDF
38. Use of a new method in reaching consensus on the cause of cytologic-histologic correlation discrepancy.
- Author
-
Raab SS, Stone CH, Wojcik EM, Geisinger KR, Dahmoush L, Garcia FU, Grzybicki DM, Janosky JE, Meier FA, and Zarbo RJ
- Subjects
- Humans, Models, Statistical, Pathology, Surgical standards, Reproducibility of Results, Single-Blind Method, Consensus, Diagnostic Errors, Observer Variation, Pathology, Surgical methods, Quality Assurance, Health Care methods
- Abstract
Pathologists exhibit very poor agreement in adjudicating the cause of cytologic-histologic correlation discrepancies, which contributes to problems in designing interventions to reduce discrepancy frequency. In this observational study, we developed a visual method of adjudicating discrepancy cause, termed the No-Blame Box method, which consisted of initially assessing specimen interpretability by separately evaluating specimen quality and the presence of tumor. Five pathologists blindly adjudicated the cause of discrepancy in pulmonary specimens from 40 patients. The kappa statistic of all pathologist pairs in adjudicating discrepancy cause using the No-Blame Box method ranged from 0.400 to 0.796, indicating acceptable to excellent agreement. Pathologists ranged in their assessment of specimen interpretability from 13% to 20%, and in no case did all 5 pathologists concur that a specimen was interpretable. Most discrepancies resulted from pathologists diagnosing noninterpretable samples. Pathologists who used the No-Blame Box showed significant agreement in the adjudication of discrepancy cause.
- Published
- 2006
- Full Text
- View/download PDF
39. The "Big Dog" effect: variability assessing the causes of error in diagnoses of patients with lung cancer.
- Author
-
Raab SS, Meier FA, Zarbo RJ, Jensen DC, Geisinger KR, Booth CN, Krishnamurti U, Stone CH, Janosky JE, and Grzybicki DM
- Subjects
- Bronchi cytology, False Negative Reactions, Humans, Lung Neoplasms pathology, Observer Variation, Diagnostic Errors, Lung pathology, Lung Neoplasms diagnosis
- Abstract
Purpose: The frequency of diagnostic error in patients who have a lung mass and a pathology specimen is as high as 15%. This study examined the role of inter-pathologist agreement in identifying the cause of error in these patients., Methods: Pathologists from six institutions reviewed the slides of 40 patients who had a pulmonary specimen false-negative diagnosis. The initial assessment of error cause arose from cytologic-histologic correlation slide review of discrepant diagnostic samples in patients who had both a bronchial brushing cytologic and surgical specimen. The cause of error was attributed either to clinical sampling (diagnostic material obtained in one but not the other sample) or interpretation (pathologist failed to identify the salient diagnostic features). The pairwise kappa (kappa) statistic was used to calculate interobserver agreement between the review and original diagnoses and between the separate review diagnoses., Results: The pairwise kappa statistic ranged widely from -0.154 to 1.0, and the pairwise kappa statistic of the slides from one institution was undetermined because that institutional pathologist never made the assessment that error was secondary to interpretation. Agreement for observers within the same institution was better than agreement between observers from different institutions., Conclusion: Pathologists exhibit poor agreement in determining the cause of error for pulmonary specimens sent for cancer diagnosis. We developed a psychosocial hypothesis (the "Big Dog" Effect) that partially explains biases in error assessment. This lack of agreement precludes confident targeting of these errors for quality improvement interventions with prospects of success across a variety of institutions.
- Published
- 2006
- Full Text
- View/download PDF
40. Errors in thyroid gland fine-needle aspiration.
- Author
-
Raab SS, Vrbin CM, Grzybicki DM, Sudilovsky D, Balassanian R, Zarbo RJ, and Meier FA
- Subjects
- Biopsy, Fine-Needle, Diagnostic Errors classification, Diagnostic Errors prevention & control, Thyroid Diseases pathology, Thyroid Gland pathology
- Abstract
Scant published data exist on redesigning pathology practice based on error data. In this first step of an Agency for Healthcare Research and Quality patient safety project, we measured the performance metrics of thyroid gland fine-needle aspiration, performed root cause analysis to determine the causes of error, and proposed error-reduction initiatives to address specific errors. Eleven cytologists signed out 1,543 thyroid gland aspirates in 2 years, and surgical pathology follow-up was obtained in 364 patients. Of the 364 patients, 91 (25.0%) had a false-negative diagnosis and 36 (9.9%) a false-positive diagnosis. Root cause analysis showed that major sources of error were pre-analytic (poor specimen quality) and analytic (interpretation of unsatisfactory specimens as nonneoplastic and lack of diagnostic category standardization). We currently are evaluating the effectiveness of error reduction initiatives that target pre-analytic and analytic portions of the diagnostic pathway.
- Published
- 2006
- Full Text
- View/download PDF
41. Double slide viewing as a cytology quality improvement initiative.
- Author
-
Raab SS, Stone CH, Jensen CS, Zarbo RJ, Meier FA, Grzybicki DM, Vrbin CM, Ohori NP, and Dahmoush L
- Subjects
- False Negative Reactions, Humans, Pathology, Clinical methods, Pathology, Clinical standards, Reproducibility of Results, Carcinoma, Small Cell diagnosis, Cytodiagnosis methods, Cytodiagnosis standards, Diagnostic Errors prevention & control, Lung Neoplasms diagnosis
- Abstract
Few studies have measured the effect of pre-sign out double viewing of cytology cases as a means to decrease error. Three Agency for Healthcare Research and Quality-funded project sites performed pre-sign out double viewing of 431 pulmonary cytology cases. Two-step or more differences in diagnosis were arbitrated as interpretive errors, and the effect of double viewing was measured by comparing the frequency of cytologic-histologic correlation-detected errors in the previous 2 years with the double-viewing period. The number of interpretive errors detected by double viewing for the 3 institutions was 2.7%, 0% and 1.9%, respectively. Double viewing did not lower the frequency of cytologic-histologic correlation false-negative errors. We conclude that double viewing detects errors in up to 1 of every 37 cases and that biases in the double-viewing process limit error detection.
- Published
- 2006
- Full Text
- View/download PDF
42. Clinical impact and frequency of anatomic pathology errors in cancer diagnoses.
- Author
-
Raab SS, Grzybicki DM, Janosky JE, Zarbo RJ, Meier FA, Jensen C, and Geyer SJ
- Subjects
- Female, Humans, Male, Observer Variation, Diagnostic Errors statistics & numerical data, Neoplasms diagnosis, Pathology, Surgical standards, Quality Assurance, Health Care
- Abstract
Background: To the authors' knowledge, the frequency and clinical impact of errors in the anatomic pathology diagnosis of cancer have been poorly characterized to date., Methods: The authors examined errors in patients who underwent anatomic pathology tests to determine the presence or absence of cancer or precancerous lesions in four hospitals. They analyzed 1 year of retrospective errors detected through a standardized cytologic-histologic correlation process (in which patient same-site cytologic and histologic specimens were compared). Medical record reviews were performed to determine patient outcomes. The authors also measured the institutional frequency, cause (i.e., pathologist interpretation or sampling), and clinical impact of diagnostic cancer errors., Results: The frequency of errors in cancer diagnosis was found to be dependent on the institution (P < 0.001) and ranged from 1.79-9.42% and from 4.87-11.8% of all correlated gynecologic and nongynecologic cases, respectively. A statistically significant association was found between institution and error cause (P < 0.001); the cause of errors resulting from pathologic misinterpretation ranged from 5.0-50.7% (the remainder were due to clinical sampling). A statistically significant association was found between institution and assignment of the clinical impact of error (P < 0.001); the aggregated data demonstrated that for gynecologic and nongynecologic errors, 45% and 39%, respectively, were associated with harm. The pairwise kappa statistic for interobserver agreement on cause of error ranged from 0.118-0.737., Conclusions: Errors in cancer diagnosis are reported to occur in up to 11.8% of all reviewed cytologic-histologic specimen pairs. To the authors' knowledge, little agreement exists regarding whether pathology errors are secondary to misinterpretation or poor clinical sampling of tissues and whether pathology errors result in serious harm., (Copyright 2005 American Cancer Society)
- Published
- 2005
- Full Text
- View/download PDF
43. Patient safety in point-of-care testing.
- Author
-
Jones BA and Meier FA
- Subjects
- Humans, Patients, Pathology standards, Point-of-Care Systems standards, Safety Management methods
- Abstract
In the authors' view, the following four points compose the current state of the question of patient safety in point-of-care testing: The collision of definitions used in this article with actual practice in point-of-care testing is evidence for the likelihood of error in this genre of clinical tests. Uncovering of latent conditions conducive to error is the objective for investigations of this likelihood. A modified Kost classification serves as a basis for determining where latent conditions appear in the point-of-care testing process and as a framework in which to recognize these errors in an error classification process. Errors in point-of-care testing are likely to arise most frequently in the steps of patient identification, specimen collection, and result reporting. In the absence of an adequate evidence base, the authors recommend as measures to build a culture of patient safety in point-of-care testing the components of the standard model of safe laboratory testing. This model inculcates the laboratory ethos of test operator competence, procedure adherence, quality control, and result integrity. These objectives can be achieved by integrating operator training, program supervision, competence assessment, and proficiency demonstration into an institution's or practice's point-of-care testing program. Based on the authors' hypothesis that medical errors in point-of-care testing, which lead to preventable adverse events most often arise in three testing processes--patient identification, specimen collation, and result reporting--they recommend ongoing monitors of these critical steps. If they are wrong, such monitoring will disprove their hypothesis; if they are right, it will measurably reduce medical error in point-of-care testing.
- Published
- 2004
- Full Text
- View/download PDF
44. A P&ID standard: what, why, how?
- Author
-
Meier FA
- Subjects
- Quality Control, Reproducibility of Results, Documentation methods, Documentation standards, Equipment and Supplies standards, Technology standards
- Published
- 2002
- Full Text
- View/download PDF
45. Operating room blood delivery turnaround time: a College of American Pathologists Q-Probe Study of 12647 units of blood components in 466 institutions.
- Author
-
Novis DA, Friedberg RC, Renner SW, Meier FA, and Walsh MK
- Subjects
- Humans, Prospective Studies, Time Factors, Transportation, Blood Banks, Operating Rooms
- Abstract
Objectives: To determine the normative distribution of time elapsed for blood bank personnel to fill nonscheduled operating room (OR) blood component orders in hospital communities throughout the United States, and to examine hospital blood bank practices associated with faster blood component delivery times., Design: Participants in the College of American Pathologists Q-Probes laboratory quality improvement program collected data prospectively on the times elapsed for blood bank personnel to fill nonscheduled emergent orders from hospital ORs for red blood cell (RBC) products, fresh frozen plasma (FFP), and platelets (PLTs). Participants also completed questionnaires describing their hospitals' and blood banks' laboratory and transfusion practices., Setting and Participants: Four hundred sixty-six public and private institutions located in 48 states in the United States (n = 444), Canada (n = 9), Australia (n = 8), the United Kingdom (n = 4), and Spain (n = 1)., Main Outcome Measures: The median time elapsed between requests for blood components by OR personnel and the retrieval of those components by blood component transport personnel, and the median time elapsed between requests for blood components by OR personnel and the arrival of those components in ORs., Results: Participants submitted data on 12 647 units of RBCs, FFP, and PLTs. The median aggregate request-to-retrieval turnaround times (TATs) for RBCs, FFP, and PLTs ranged from 30 to 35 minutes, and the median aggregate request-to-arrival TATs for RBCs, FFP, and PLTs ranged from 33 to 39 minutes. Most of the TAT was consumed by events occurring prior to, rather than after release of components from blood banks. Shorter prerelease TATs were associated with having surgical schedules that listed patients' names and procedures available to blood bank personnel prior to surgeries, and having adequate clotted specimens in the blood bank and completed type-and-screen procedures performed before requests for blood components were submitted to blood banks. Among the fastest-performing 10% of participants (90th percentile and above), request-to-retrieval TATs ranged from 12 to 24 minutes for the 3 blood components, whereas among the slowest-performing 10% of participants (10th percentile and below), request-to-retrieval TATs ranged from 63 to 115 minutes for the 3 components. Median TATs ranged from 33 to 37 minutes for the 3 components. Institutions with TATs in the fastest-performing 25th percentile more frequently stored cross-matched RBCs in the OR daily, stocked PLTs for unexpected surgical use, stored PLTs in or near the OR, and had laboratory rather than nonlaboratory personnel deliver components to the OR than did those institutions with TATs in the slowest-performing 25th percentile., Conclusions: Hospital blood bank personnel can deliver blood components to the OR in slightly longer than 30 minutes, measured from the time that those units are requested by OR personnel. Practices aimed at saving time before components are released from blood banks will be more efficient in reducing overall TAT than those practices aimed at saving time after components are released from blood banks. Specific practices associated with shorter blood delivery TATs included providing blood bank personnel with access to the names of surgical patients potentially requiring blood components, having pretransfusion testing completed on those patients prior to surgery, having ample blood products on hand, and having laboratory personnel control blood product delivery.
- Published
- 2002
- Full Text
- View/download PDF
46. A 16-year-old boy with rapidly progressing pulmonary fibrosis.
- Author
-
Lo Sasso AA, Osterhoudt K, Meier FA, Costarino AT Jr, and Cullen EJ Jr
- Subjects
- Adolescent, Disease Progression, Fatal Outcome, Humans, Lung pathology, Male, Poisoning diagnosis, Pulmonary Alveoli pathology, Pulmonary Fibrosis pathology, Herbicides poisoning, Paraquat poisoning, Pulmonary Fibrosis chemically induced, Pulmonary Fibrosis diagnosis
- Published
- 2002
- Full Text
- View/download PDF
47. Performance of a predictive model for streptococcal pharyngitis in children.
- Author
-
Attia MW, Zaoutis T, Klein JD, and Meier FA
- Subjects
- Adolescent, Chi-Square Distribution, Child, Child, Preschool, Female, Humans, Infant, Male, Observer Variation, Predictive Value of Tests, Probability, Prospective Studies, ROC Curve, Regression Analysis, Sensitivity and Specificity, Severity of Illness Index, Streptococcal Infections microbiology, Decision Support Techniques, Pharyngitis microbiology, Streptococcal Infections diagnosis, Streptococcus pyogenes isolation & purification
- Abstract
Context: Group A beta-hemolytic streptococcus (GABHS) pharyngitis is a common childhood illness. The clinical diagnosis is difficult to determine and laboratory tests have limitations; hence, the condition is generally overdiagnosed and overtreated. Several clinical pediatric-specific predictive models have been published but none have been prospectively studied., Objective: To test the performance of a previously published predictive model for GABHS pharyngitis in children in different clinical settings and during different seasons., Design: Prospective cohort study., Settings: Pediatric emergency department and 2 pediatric outpatient clinics., Patients: Children aged between 1 and 18 years with pharyngitis on initial examination at study sites between April 1, 1999, and March 31, 2000., Interventions: Recording of clinical features during initial evaluation using a standardized form and recovery of GABHS from patients' throats using reference standard methods., Main Outcome Measures: Posttest probability for GABHS positive throat culture associated with the model's positive predictors (moderate to severe tonsillar swelling, cervical lymphadenopathy [moderate to severe tenderness and enlargement of cervical lymph nodes], scarletiniform rash, and the absence of coryza) and the models' negative predictors (absence of the above signs and the presence of coryza)., Results: Of 587 patients analyzed, 218 (37%) had a positive throat culture for GABHS. Forty-nine percent were boys. Mean +/- SD age was 6.7 +/- 3.9 years. There was no difference between the subsets within the sample. The posttest probability values for a positive throat culture associated with positive and negative predictors of the model were 79% and 12%, respectively., Conclusions: A pediatric predictive model for GABHS pharyngitis performed better than physicians' subjective estimates for a positive throat culture and was comparable with a rapid antigen detection test. The model performed consistently well in different populations and across seasons. It can be useful if reliable microbiological testing and/or follow-up are not attainable.
- Published
- 2001
- Full Text
- View/download PDF
48. Reduction in levels of triiodothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome.
- Author
-
Mainwaring RD, Healy RM, Meier FA, Nelson JC, and Norwood WI
- Subjects
- Adult, Cardiopulmonary Bypass, Female, Follow-Up Studies, Humans, Infant, Infant Welfare, Length of Stay, Male, Radioimmunoassay methods, Triiodothyronine blood, Hypoplastic Left Heart Syndrome blood, Hypoplastic Left Heart Syndrome surgery, Plastic Surgery Procedures, Triiodothyronine analysis
- Abstract
Objective: Thyroid hormone has important effects on cardiovascular performance. This study was performed to evaluate the changes in levels of triiodothyronine following the first stage of reconstruction for hypoplastic left heart syndrome., Methods: We enrolled 14 newborns with hypoplastic left heart syndrome scheduled for first stage reconstruction. Blood samples were obtained pre-, intra-, and post-operatively. Levels of free and total triiodothyronine were determined by radioimmunoassay. Statistical comparison was performed using Wilcoxon's signed rank test., Results: The levels of free triiodothyronine decreased from a baseline of 355+/-31 pg/dl to 205+/-21 pg/dl upon the institution of bypass, and declined to a level of 135+/-9 pg/dl at 24 hours postoperatively. Similarly, levels of total triiodothyronine decreased from 101+/-15 ng/dl to 65+/-4 ng/dl upon the institution of bypass, and continued to decline during the first 24 hours postoperatively. Levels of free and total triiodothyronine had returned to baseline by the fifth postoperative day., Conclusions: The data demonstrate significant decreases in levels of free and total triiodothyronine during the early postoperative period. These changes in levels of thyroid hormone may have adverse effects on cardiac function during this phase of recovery.
- Published
- 2001
- Full Text
- View/download PDF
49. Reference laboratory telephone service quality.
- Author
-
Dale JC, Novis DA, and Meier FA
- Subjects
- Humans, Pathology, Clinical statistics & numerical data, Quality Assurance, Health Care, Pathology, Clinical standards, Telephone
- Abstract
Objectives: To establish the rates with which reference laboratories resolve inquiries telephoned to them from primary laboratories and to identify reference laboratory practices associated with higher rates of inquiry resolution., Design and Participants: For 2 months, or until 50 contacts had occurred, 545 primary laboratories participating in the College of American Pathologists Q-Probes laboratory quality improvement program prospectively documented and characterized telephone inquiries they made to a reference laboratory of their choice. Participants also cataloged their own laboratory's demographic and practice characteristics and their reference laboratory's customer service characteristics., Main Outcome Measure: Rates with which reference laboratories resolved telephone inquiries., Results: Participants characterized 11 031 (78.7%) of 14 017 telephone inquiries as resolved by the reference laboratories. Ranked according to inquiry resolution rates, primary laboratories in the 90th percentile characterized reference laboratories as resolving 100% of their inquiries; those in the 10th percentile characterized reference laboratories as resolving only 54.2% of their inquiries. The rate of resolved inquiries was significantly higher (P =.0047) for participants using reference laboratories with 24-hour customer service than it was for participants using reference laboratories with less than 24-hour service. Most primary laboratories (80.9%) chose to monitor 1 of 11 national reference laboratories; in this subset, median rates of inquiry resolution ranged from 90.2% to 55.0% (P <.0001), despite no significant variation in other measured customer service characteristics., Conclusions: Primary laboratories experience significant differences in the rates with which reference laboratories resolve telephone inquiries. The performance benchmark for reference laboratories is resolution of at least 90% of telephone inquiries from primary laboratory customers.
- Published
- 2001
- Full Text
- View/download PDF
50. Kaposiform hemangioendothelioma of the thymus.
- Author
-
Wilken JJ, Meier FA, and Kornstein MJ
- Subjects
- Biomarkers, Tumor analysis, Hemangioendothelioma chemistry, Hemangioendothelioma surgery, Humans, Immunoenzyme Techniques, Infant, Sarcoma, Kaposi chemistry, Sarcoma, Kaposi surgery, Thymus Neoplasms chemistry, Thymus Neoplasms surgery, Hemangioendothelioma pathology, Sarcoma, Kaposi pathology, Thymus Neoplasms pathology
- Abstract
Kaposiform hemangioendothelioma is a rare pediatric neoplasm that presents most commonly in the soft tissues. We report the case of a 1-month-old infant who presented with stridor and was found to have a diffusely infiltrating tumor in the thymus that extended into the pericardium and up the carotid sheaths. Histologic examination revealed a vascular tumor infiltrating among the lobules of the lymphocyte-depleted thymus. The lesion had features of both a capillary hemangioma and Kaposi sarcoma. Immunoperoxidase studies on formalin-fixed, paraffin-embedded tissue demonstrated the neoplastic endothelial cells to be positive for vascular markers CD31 and CD34. Antibody to factor VIII-related antigen labeled feeding vessels, but failed to stain the lobules of tumor. Although these tumors have been treated in a fashion similar to capillary hemangiomas in the past, it may be important to differentiate Kaposiform hemangioendotheliomas because of their association with Kasabach-Merritt syndrome and recent success with more aggressive chemotherapy regimens.
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.